XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Operating expenses:        
Research and development $ 30,004 $ 33,062 $ 90,450 $ 79,132
General and administrative 12,946 12,442 40,318 34,890
Total operating expenses 42,950 45,504 130,768 114,022
Loss from operations (42,950) (45,504) (130,768) (114,022)
Total other income (loss), net:        
Interest income 668 253 978 1,233
Other income, (loss), net 210 (259) (634) (1,232)
Loss before income taxes (42,072) (45,510) (130,424) (114,021)
Income tax expense     150  
Net loss $ (42,072) $ (45,510) $ (130,574) $ (114,021)
Net loss per share - basic $ (0.50) $ (0.72) $ (1.83) $ (1.82)
Net loss per share - diluted $ (0.50) $ (0.72) $ (1.83) $ (1.82)
Weighted-average common shares outstanding - basic 84,948,837 62,962,434 71,213,219 62,588,898
Weighted-average common shares outstanding - diluted 84,948,837 62,962,434 71,213,219 62,588,898
Comprehensive loss:        
Net loss $ (42,072) $ (45,510) $ (130,574) $ (114,021)
Other comprehensive income (loss), net of tax:        
Unrealized (loss) gain on available-for-sale securities (119) (3) (408) 23
Foreign currency translation adjustment   (105)   (44)
Total other comprehensive loss (119) (108) (408) (21)
Comprehensive loss $ (42,191) $ (45,618) $ (130,982) $ (114,042)